Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST).
Simona LattanziLaura CanafogliaMaria Paola CaneviniSara CasciatoEmanuele Cerulli IrelliValentina ChiesaFilippo DaineseGiovanni De MariaGiuseppe DidatoGiovanni FalcicchioMartina FanellaEdoardo FerlazzoMassimo GangitanoFilippo Sean GiorgiAngela La NeveOriano MecarelliElisa MontalentiAlessandra MoranoFederico PiazzaPatrizia PulitanoPier Paolo QuaratoFederica RanzatoEleonora RosatiLaura TassiCarlo Di Bonaventuranull nullPublished in: Drugs & aging (2022)
Adjunctive brivaracetam was efficacious, had good tolerability, and no new or unexpected safety signals emerged when used to treat older patients with uncontrolled focal seizures in clinical practice. Adjunctive brivaracetam can be a suitable therapeutic option in this special population.